IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.476
EU - Europa 3.339
AS - Asia 2.402
SA - Sud America 356
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 16.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.398
SG - Singapore 1.380
UA - Ucraina 918
DE - Germania 529
IT - Italia 518
CN - Cina 475
RU - Federazione Russa 318
BR - Brasile 315
FI - Finlandia 263
IE - Irlanda 219
SE - Svezia 183
TR - Turchia 140
GB - Regno Unito 136
KR - Corea 104
VN - Vietnam 84
CA - Canada 64
HK - Hong Kong 64
FR - Francia 60
AT - Austria 56
IN - India 45
NL - Olanda 26
CZ - Repubblica Ceca 25
IR - Iran 20
TG - Togo 20
BE - Belgio 19
JP - Giappone 16
AR - Argentina 15
PL - Polonia 15
EG - Egitto 14
ES - Italia 11
IQ - Iraq 11
ZA - Sudafrica 10
MX - Messico 9
PK - Pakistan 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 6
GR - Grecia 6
MA - Marocco 6
BD - Bangladesh 5
CL - Cile 5
IL - Israele 5
RO - Romania 5
UZ - Uzbekistan 5
BO - Bolivia 4
CO - Colombia 4
EC - Ecuador 4
EU - Europa 4
ID - Indonesia 4
LK - Sri Lanka 4
AZ - Azerbaigian 3
CR - Costa Rica 3
EE - Estonia 3
HR - Croazia 3
KG - Kirghizistan 3
LT - Lituania 3
PE - Perù 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 16.640
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.436
Fairfield 1.025
Houston 884
Ann Arbor 880
Singapore 719
Chandler 707
Jacksonville 577
Ashburn 507
Wilmington 497
Seattle 423
Dearborn 362
Cambridge 326
Boardman 325
Dublin 216
Princeton 208
Beijing 206
Udine 166
Izmir 132
Seoul 98
Des Moines 81
Dong Ket 80
San Diego 75
Nuremberg 59
Ogden 55
Hong Kong 52
Norwalk 43
Ottawa 42
Redmond 41
Munich 40
Los Angeles 39
Nanjing 33
Milan 29
São Paulo 28
Hefei 27
Trieste 27
Belluno 26
Düsseldorf 24
New York 23
Frankfurt am Main 22
Brno 21
Lomé 20
London 20
San Mateo 20
Helsinki 19
Santa Clara 19
Vienna 19
Brussels 18
Auburn Hills 15
Falls Church 15
Lauterbourg 15
Rome 15
Dallas 14
Warsaw 14
Amsterdam 13
Toronto 13
Guangzhou 12
Lappeenranta 12
Grafing 11
Kunming 11
Phoenix 11
Shanghai 11
Turku 11
Augusta 10
Saint Louis 10
Chengdu 9
Hyderabad 9
Nanchang 9
Padova 9
Simi Valley 9
Ardabil 8
Belo Horizonte 8
Brooklyn 8
Leawood 8
Rio de Janeiro 8
Wuhan 8
Xi'an 8
Brasília 7
Redwood City 7
Shenzhen 7
Atlanta 6
Baghdad 6
Boston 6
Colombo 6
Curitiba 6
Jinan 6
Montreal 6
Paris 6
Portsmouth 6
Tavagnacco 6
Verona 6
Athens 5
Buenos Aires 5
Chicago 5
Florence 5
Fuzhou 5
Goiânia 5
Jiaxing 5
Moscow 5
Mumbai 5
Ribeirão Preto 5
Totale 11.147
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 165
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 156
Pain management in cryoglobulinaemic syndrome 150
Validation of the classification criteria for cryoglobulinaemic vasculitis. 149
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 146
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 144
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 143
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 137
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 136
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 136
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 136
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 133
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 131
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 131
Use of teriparatide in osteoporosis due to active rheumatic diseases 130
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 130
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 130
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 129
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 129
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 127
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 127
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 126
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 125
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 125
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 123
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 122
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 122
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 122
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 121
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 121
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 121
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 120
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 120
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 119
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 119
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 119
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 118
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 118
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 118
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 116
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 115
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 115
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 114
Classification of cryoglobulinemic vasculitis 113
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 113
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 112
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 111
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 111
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 110
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 110
Gastrointestinal Involvement in Systemic Vasculitis 109
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 109
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 106
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 105
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 104
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 103
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 101
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 101
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 101
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 100
Myositis in primary sjögren's syndrome: data from a multicenter cohort 100
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 100
Preliminary classification criteria for the cryoglobulinaemic vasculitis 99
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 99
efficacy of methotrexate in polymyalgia rheumatica 97
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 97
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 96
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 96
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 95
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 94
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 94
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 94
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 93
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 93
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 93
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 93
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 93
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 91
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 90
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 90
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 90
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 88
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 87
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 86
Primary sjögren's syndrome as a multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients 86
Early Psoriatic Arthritis Versus Early Seronegative Rheumatoid Arthritis: Role of Dermoscopy Combined with Ultrasonography for Differential Diagnosis 86
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 85
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 84
Sjögren's Syndrome-Associated Lymphoma 83
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 82
Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue 82
Gastrointestinal involvement in systemic vasculitis 82
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 81
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 81
Long-term response to rituximab in 36 patents with the reumatoid arthritis: a single centre wxperience. 80
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease. 80
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 79
Outcome of Pregnancy in Italian Patients with Primary Sjogren Syndrome. 77
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 77
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 76
Totale 10.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020308 0 0 0 0 0 0 0 0 0 0 85 223
2020/20212.306 78 249 52 252 103 253 66 237 485 83 273 175
2021/20221.559 61 151 86 127 36 47 90 101 25 214 352 269
2022/20231.883 227 87 38 198 198 502 35 135 271 36 73 83
2023/2024712 99 58 27 18 135 83 30 56 92 57 20 37
2024/20253.735 114 380 228 152 234 222 319 330 693 480 583 0
Totale 17.528